Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019

SELL
$4.99 - $6.16 $5.72 Million - $7.07 Million
-1,146,928 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$5.92 - $7.41 $4.94 Million - $6.18 Million
-833,722 Reduced 42.09%
1,146,928 $6.94 Million
Q1 2019

May 15, 2019

BUY
$6.8 - $7.4 $1.06 Million - $1.15 Million
155,650 Added 8.53%
1,980,650 $14.3 Million
Q4 2018

Feb 14, 2019

BUY
$3.99 - $7.82 $7.28 Million - $14.3 Million
1,825,000 New
1,825,000 $13.5 Million

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $396M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.